Company intelligence / Profile preview

Arcinova

Alnwick, England, United Kingdom

Ownership: Private
Employees: ~160
Development stage: Other

Overview

Arcinova is a multiservice contract development and manufacturing organization providing drug substance, drug product, bioanalysis and isotope labelling services from preclinical and candidate selection through early clinical development and Phase II, supporting global pharma and biotech customers rather than developing its own therapeutic pipeline.[1][2][4][6]

Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Quotient Sciences (integrated drug substance, drug product and clinical testing offering)[2][5][6]

Beyond the preview

Go deeper on Arcinova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arcinova.

Explore the full profile